Bain Capital Public Equity Management’s Immune Design Corp. IMDZ Stock Holding History

Bain Capital Public Equity Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-892,061	Closed	-$1.16M	–	81
2018 Q4	$1.16M	Sell	892,061 -247,883	-22%	-$431K	0.11%	46
2018 Q3	$3.93M	Sell	1,139,944 -81,424	-7%	-$306K	0.28%	45
2018 Q2	$5.56M	Sell	1,221,368 -459,619	-27%	-$1.83M	0.37%	42
2018 Q1	$5.55M	Sell	1,680,987 -1,635,782	-49%	-$5.79M	0.4%	45
2017 Q4	$12.9M	Buy	3,316,769 +2,017,756	+155%	+$11M	0.94%	30
2017 Q3	$13.4M	Buy	1,299,013 +909,613	+234%	+$8.95M	0.85%	32
2017 Q2	$3.8M	Buy	389,400 +310,433	+393%	+$2.18M	0.23%	47
2017 Q1	$537K	Buy	+78,967	New	+$457K	0.04%	57

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Bain Capital Public Equity Management's IMDZ Position: Q1 2019 in Review

Bain Capital Public Equity Management sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 892,061 shares — an estimated $1.16M sold.

Bain Capital Public Equity Management first reported a position in IMDZ in Q1 2017 and held it in 8 quarters. The position peaked at $13.4M in Q3 2017. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Bain Capital Public Equity Management reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Bain Capital Public Equity Management sold 892,061 Immune Design Corp. shares in Q1 2019, an estimated $1.16M.
Bain Capital Public Equity Management first reported a position in Immune Design Corp. in Q1 2017 and held it in 8 quarters.
Bain Capital Public Equity Management's Immune Design Corp. position peaked at $13.4M in Q3 2017.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Bain Capital Public Equity Management's 13F filing for Q1 2019, filed 15 May 2019.